Pacific Biosciences Of California (PACB) Asset Utilization Ratio (2011 - 2026)

Pacific Biosciences Of California's Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.2 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 42.24% year-over-year to 0.2 in Q1 2026; TTM through Mar 2026 was 0.2, a 42.24% increase from a year earlier, with the FY2025 full-year figure at 0.16, up 52.77% from the prior year.
• Asset Utilization Ratio improved to 0.2 in Q1 2026 per PACB's latest filing, from 0.2 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.2 in Q1 2026 and bottomed at 0.07 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.11 (2024), against an average of 0.12.
• Across the five-year window, Asset Utilization Ratio slumped 41.41% in 2022 and jumped 77.41% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.07 in 2022, then jumped by 53.78% to 0.11 in 2023, then gained by 3.27% to 0.11 in 2024, then jumped by 77.41% to 0.2 in 2025, then climbed by 1.34% to 0.2 in 2026.
• Per Business Quant, the three latest PACB Asset Utilization Ratio figures stand at 0.2 (Q1 2026), 0.2 (Q4 2025), and 0.19 (Q3 2025).